News
Joint “Rapid relative effectiveness assessment of new pharmaceuticals for the treatment of chronic Hepatitis C”
The purpose of the assessment is to evaluate multiple new pharmaceuticals for the treatment of Chronic Hepatitis C. Final version of the assessment was published
Internal validity of non-randomised studies (NRS) on interventions Guideline Final Jul 2015
Internal validity of non-randomised studies (NRS) on interventions_Guideline_Final Jul 2015
HTA Core Model_ Guiding principles on use
The HTA Core Model_Guiding principles on use_20151218
EUnetHTA-EMA f-t-f meeting summary 20150508, London, UK
Please find below the summary of the EUnetHTA / EMA face-to-face meeting, 8 May 2015, in London, UK. 2015-05-08 EMA-EUnetHTA – Meeting minutes – Final
EUnetHTA-EMA f-t-f meeting summary 20141209, Diemen, the Netherlands
Please find below the summary of the EUnetHTA / EMA face-to-face meeting, 9 December 2015 in Diemen, the Netherlands EMA EUnetHTA Diemen meeting Summary_Final_20150302
EUnetHTA Plenary Assembly 2015 – Summary report
EUnetHTA Plenary Assembly, 28-29 May 2015, Copenhagen, Denmark . Summary report and appendices. Find the full summary report below. Appendix A_20150528-29_EUnetHTA Plenary Assembly_FINAL Appendix B_SEED_Update
EUnetHTA methodological guideline – Methods for health economic evaluations
The methodological guideline on “Methods for health economic evaluations” was developed by WP7, Subgroup 3. The work with the present guideline was initiated to set
EUnetHTA letter to the European Commission’s DG Research and Innovation on methodological issues of high importance
This letter from EUnetHTA to European Commission’s DG Research and Innovation, EUnetHTA outlines a number of methodological issues that are of high importance and which
EUnetHTA Evidence Submission Template
The EUnetHTA Submission Template is a flexible tool that reflects all national evidence requirements for reimbursement in Europe. The inclusion of all national requirements means
EUnetHTA and MedTech industry expert meeting, summary of discussion
The meeting took place on October 16, 2015 at Eucomed / EDMA offices in Brussels, Belgium with participants coming from organisations-members of Eucomed, EDMA, COCIR
